AAAAAA

   
Results: 1-10 |
Results: 10
PHASE I II TRIAL OF THE IL-2 DNA/DMRIE/DOPE LIPID COMPLEX AS AN IMMUNOTHERAPEUTIC AGENT BY DIRECT GENE-TRANSFER IN PATIENTS WITH ADVANCED MELANOMA, RENAL-CELL CARCINOMA, AND SARCOMA/
Authors: RUBIN J GALANIS E BURCH P HERSH EM SPIER C AKPORIAYE E GONZALEZ R RINEHART JJ SOBOL RE SONDAK VK STAHL SM
Citation: J. Rubin et al., PHASE I II TRIAL OF THE IL-2 DNA/DMRIE/DOPE LIPID COMPLEX AS AN IMMUNOTHERAPEUTIC AGENT BY DIRECT GENE-TRANSFER IN PATIENTS WITH ADVANCED MELANOMA, RENAL-CELL CARCINOMA, AND SARCOMA/, Cancer gene therapy, 4(6), 1997, pp. 125-125
MORPHOLOGIC REVIEW OF 2100 SWOG PATIENTS SUPPORTS THE REAL CLASSIFICATION OF LYMPHOMA AS CLINICALLY USEFUL
Authors: GROGAN T MILLER T DAHLBERG S BRAZIEL R BANKS P NATHWANI B KJELDSBERG C TUBBS R FOUCAR K LEITH C SPIER C SCHNITZER B GULLEY M FISHER R
Citation: T. Grogan et al., MORPHOLOGIC REVIEW OF 2100 SWOG PATIENTS SUPPORTS THE REAL CLASSIFICATION OF LYMPHOMA AS CLINICALLY USEFUL, Laboratory investigation, 74(1), 1996, pp. 650-650
MODULATION OF ANTHRACYCLINE RESISTANCE IN POOR-RISK ACUTE MYELOID-LEUKEMIA (AML) WITH SDZ PSC-833 - RESULTS OF A PHASE I II MULTICENTER STUDY/
Authors: LIST AF KARANES C DORR R SPIER C GROGAN T GREER J MOORE J WEINBERGER J SCHILLER G DALTON W PEARCE T LITCHMAN M
Citation: Af. List et al., MODULATION OF ANTHRACYCLINE RESISTANCE IN POOR-RISK ACUTE MYELOID-LEUKEMIA (AML) WITH SDZ PSC-833 - RESULTS OF A PHASE I II MULTICENTER STUDY/, Blood, 88(10), 1996, pp. 1156-1156
GENERATION OF CYTOTOXIC EFFECTOR-CELLS AGAINST HUMAN-MELANOMA
Authors: LEONG SPL ZHOU YM GRANBERRY ME WANG TF GROGAN TM SPIER C WHITE R MEHTA A LIN AY
Citation: Spl. Leong et al., GENERATION OF CYTOTOXIC EFFECTOR-CELLS AGAINST HUMAN-MELANOMA, Cancer immunology and immunotherapy, 40(6), 1995, pp. 397-409
A SOUTHWEST-ONCOLOGY-GROUP (SWOG) ANALYSIS OF THE ANAPLASTIC LARGE-CELL LYMPHOMA (ALCL) ENTITIES IN THE REVISED EUROPEAN-AMERICAN LYMPHOMA (REAL) CLASSIFICATION
Authors: GROGAN T KJELDSBERG C TUBBS R DAHLBERG S BRAZIEL R FOUCAR C LEITH C SPIER C GAYNOR E MILLER T FISHER R
Citation: T. Grogan et al., A SOUTHWEST-ONCOLOGY-GROUP (SWOG) ANALYSIS OF THE ANAPLASTIC LARGE-CELL LYMPHOMA (ALCL) ENTITIES IN THE REVISED EUROPEAN-AMERICAN LYMPHOMA (REAL) CLASSIFICATION, Laboratory investigation, 72(1), 1995, pp. 111-111
EFFECT OF AGGRESSIVE DAUNOMYCIN THERAPY ON SURVIVAL IN ACUTE PROMYELOCYTIC LEUKEMIA
Authors: HEAD D KOPECKY KJ WEICK J FILES JC RYAN D FOUCAR K MONTIEL M BICKERS J FISHLEDER A MILLER M SPIER C HANSON C BITTER M BRAZIEL B MILLS G WELBORN J WILLIAMS W HEWLETT J WILLMAN C APPELBAUM FR
Citation: D. Head et al., EFFECT OF AGGRESSIVE DAUNOMYCIN THERAPY ON SURVIVAL IN ACUTE PROMYELOCYTIC LEUKEMIA, Blood, 86(5), 1995, pp. 1717-1728
RECURRENT BEG ULCERATIONS AS THE INITIAL CLINICAL MANIFESTATION AT KLINEFELTERS-SYNDROME
Authors: SPIER C SHEAR NH LESTER RS
Citation: C. Spier et al., RECURRENT BEG ULCERATIONS AS THE INITIAL CLINICAL MANIFESTATION AT KLINEFELTERS-SYNDROME, Archives of dermatology, 131(2), 1995, pp. 230-230
MAST-CELL GROWTH-FACTOR (C-KIT LIGAND) RESTORES GROWTH OF MULTIPOTENTPROGENITORS IN MYELODYSPLASTIC SYNDROME
Authors: GLINSMANNGIBSON B SPIER C BAIER M TAETLE R BROUDY VC LIST AF
Citation: B. Glinsmanngibson et al., MAST-CELL GROWTH-FACTOR (C-KIT LIGAND) RESTORES GROWTH OF MULTIPOTENTPROGENITORS IN MYELODYSPLASTIC SYNDROME, Leukemia, 8(5), 1994, pp. 827-832
EXPRESSION OF THE EV11 GENE IN CHRONIC MYELOGENOUS LEUKEMIA IN BLAST CRISIS
Authors: RUSSELL M THOMPSON F SPIER C TAETLE R
Citation: M. Russell et al., EXPRESSION OF THE EV11 GENE IN CHRONIC MYELOGENOUS LEUKEMIA IN BLAST CRISIS, Leukemia, 7(10), 1993, pp. 1654-1657
PHASE-I II TRIAL OF CYCLOSPORINE AS A CHEMOTHERAPY-RESISTANCE MODIFIER IN ACUTE-LEUKEMIA/
Authors: LIST AF SPIER C GREER J WOLFF S HUTTER J DORR R SALMON S FUTSCHER B BAIER M DALTON W
Citation: Af. List et al., PHASE-I II TRIAL OF CYCLOSPORINE AS A CHEMOTHERAPY-RESISTANCE MODIFIER IN ACUTE-LEUKEMIA/, Journal of clinical oncology, 11(9), 1993, pp. 1652-1660
Risultati: 1-10 |